SUBSCRIBE

Breaking News on Global Pharmaceutical Technology & Manufacturing

Processing: Top Headlines

Dispatches from Cell Therapy Manufacturing & Gene Therapy Congress

Vendors must collaborate to develop cell therapy production automation, experts

04-Feb-2016 - Cell therapy development and production will not be sustainable unless there is a vendor-led shift to automated processes, said experts in Brussels yesterday.

Related news

News in brief

Teva upskilling of UK sterile site could lead to loss of 80 jobs

03-Feb-2016 - Up to 80 UK sterile manufacturing jobs could be lost as part of a technical overhaul at a Teva site near Liverpool.

Reneuron gets US patent for non-toxic cell cryopreservation system

02-Feb-2016 - Reneuron has been granted a US patent for a cryopreservation technology that does not rely on toxic reagents and says it would consider licensing it to other stem cell therapy developers on a case-by-case basis.

Thawing market heats up: Biocision expands cell therapy tech offering

29-Jan-2016 - Biocision has revamped its cell thawing platform to accommodate larger vial sizes and started developing an automated system for cell therapies in cryopreservation bags.

Regulatory reforms to reshape drug manufacturing in China says expert

28-Jan-2016 - More plants in China will close says a US-based analyst who predicts that some drugmakers' inability to comply with stricter quality rules will create an opportunity for those that can.

Novartis: Centralised manufacturing unit will harness tech, not reduce network

28-Jan-2016 - Plans to centralise its manufacturing operations will optimise use of new technologies across Novartis’s divisions without resulting in any additional facility closures, the firm says.

Hermes adapts food coating technique for API taste masking

26-Jan-2016 - Hermes Pharma has added hot melt coating capabilities to its offering and hopes the food industry technique will win it pharma customers with unpleasant tasting APIs.

GSK biopharmaceutical trade secrets defendant still "at large"

26-Jan-2016 - Yan Mei, a defendant charged with stealing GlaxoSmithKline (GSK) trade secrets including biopharmaceutical manufacturing processes, remains at large, a spokesperson for the US Attourney's office told us yesterday.

Processing: Featured news

Key Industry Events

 

Access all events listing

Our events, Shows & Conferences...